Ara
Toplam kayıt 5, listelenen: 1-5
Tyrosine kinase inhibitors and COVID-19
(Sage Publications Ltd, 2020)
[No Abstract Available]
Convalescent plasma therapy in patients with COVID-19 (Letter)
(Pergamon-Elsevier Science Ltd, 2021)
[No Abstract Available]
Convalescent plasma therapy in patients with COVID-19
(Wiley, 2020)
There are currently no licensed vaccines or therapeutics for COVID-19. Anti-SARS CoV-2 antibody-containing plasmas, obtained from the recovered individuals who had confirmed COVID-19, have been started to be collected using ...
The outcome of COVID-19 in patients with hematological malignancy (Letter)
(Wiley, 2021)
[No Abstract Available]
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
(Pergamon-Elsevier Science Ltd, 2021)
SARS-CoV-2 attaches to the angiotensin-converting enzyme 2 (ACE-2) receptor on human cells. The virus causes hypercytokinemia, capillary leak, pulmonary edema, acute respiratory distress syndrome, acute cardiac injury, and ...